A
AgNovos Healthcare
Regenerative medicine for osteoporosis and bone disease
About AgNovos Healthcare
AgNovos Healthcare is a privately-held medical device company developing therapies for bone health, with a primary focus on osteoporosis. The company was founded in 2012 by Dr. James Howe, an orthopedic surgeon with over 34 years of experience in patient care, research, and bone health science. Dr. Howe's extensive background in orthopedics, prosthetic design, and the management of hip and knee arthritis inspired his 20-year effort to develop the company's first product.
The company's core technology is the Local Osteo-Enhancement Procedure (LOEP), a minimally invasive procedure designed to address bone loss. The flagship product, the OSSURE™ LOEP kit, involves implanting a unique, calcium-based, resorbable, triphasic material called AGN1. This material is designed to be osteoconductive, meaning it is resorbed and replaced by new bone, which can immediately and durably increase bone density and strength. AgNovos offers different kits for various applications, including the CE-marked OSSURE LOEP kit for forming new bone in the pelvis and extremities, and the investigational AGN1 LOEP SV (Small Volume) kit for treating vertebral compression fractures. The AGN1 LOEP SV kit has received a Breakthrough Device designation and an Investigational Device Exemption (IDE) from the U.S. FDA.
AgNovos operates on a model of rigorous clinical research to validate its technology and gain market access. The company is conducting multiple large-scale clinical studies, such as the CONFIRM and RESTORE trials, to gather data on the safety and efficacy of its treatments, which is crucial for entering new markets like the U.S. and Japan. The company generates revenue through the commercialization of its CE-marked products in select markets and has entered into strategic partnerships, such as an exclusive option agreement with Asahi Kasei Pharma for commercialization in Japan. AgNovos Healthcare is headquartered in New York City, with research, development, manufacturing, and support services in Rockville, Maryland.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2023 | $32M | $126M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for AgNovos Healthcare is 3.3K monthly website visits, up 135.7% over the last three months. AgNovos Healthcare's team declined 4.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
AgNovos Healthcare in the Rockville ecosystem
The AgNovos Healthcare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AgNovos Healthcare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AgNovos Healthcare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









